ÌÇÐÄvlog´«Ã½

Tissue Microarray Market Analysis

The tissue microarray market is expected to register a CAGR of more than 10.3% during the forecast period.

• The COVID-19 pandemic was an unprecedented health concern and had significantly impacted the tissue microarray market. The pandemic turned a spotlight on the molecular diagnostics industry worldwide, with the rapid development of diagnostics, fast-tracked regulatory clearances, and ramped-up distribution in various regions to help curb the spread of the virus. For instance, as of January 2022, a published article in Karger had reported that tissue microarrays incorporating a total of 879 tissue cores from conjunctival (n = 84), sinonasal (n = 95), and lung (bronchiolar/alveolar; n = 96) specimens were investigated for protein expression by immunohistochemistry. The study confirmed and extended previous findings and contributed to a better understanding of potential SARS-CoV-2 infection sites along the human respiratory tract. Such studies had indicated significant demand for tissue microarray products amid the pandemic. Also, with the introduction of vaccine development and the upliftment of lockdown restrictions, the market was expected to witness positive growth in the coming period.
• The growth of the market can be attributed to factors such as growing research and development in drug discovery, the rising burden of cancer, and increasing demand for accurate diagnostic methods.
• The rising prevalence of cancer is driving the demand for tissue microarray products. For instance, the increasing cancer burden is one of the major factors driving the market. According to the International Agency for Research on Cancer (IARC) 2023, the global incidence of cancer is expected to reach 24.6 million by the year 2030 and 30.2 million by 2040. Furthermore, according to the Cancer Statistics Japan 2023, there were 96,400 prostate cancer cases diagnosed in Japan in 2022, compared to 95,400 in 2021. Thus, the demand for tissue microarrays is increasing in cancer research to analyze the biopsy or tumor samples, thereby anticipated to drive the market growth.
• Additionally, strategic initiatives taken by market players are also propelling the growth of the market. For instance, in March 2021, Oxford BioDynamics Plc and Agilent Technologies signed a supply and resale agreement for the manufacture and sale of the new EpiSwitch Explorer Array Kit. Furthermore, in March 2023, 3DHISTECH, a manufacturer of digital slide scanners, software applications for digital slides, and other products, including tissue microarray machines, and Epredia, a member of the PHC Group (headquartered in Japan) inaugurated a Pathology Innovation Incubator to develop methods and equipment for faster and more precise diagnosis of cancer and tumor lesions. Therefore, the partnership among key players is anticipated to contribute to the market studied due to the increased adoption of microarrays.
• Furthermore, the rising applications of tissue microarray in high throughput screening are anticipated to bolster the market growth. For instance, according to the study published in Scientific Reports in November 2022, tissue microarrays are frequently used for the rapid analysis of large numbers of tissue samples, and the use of tissue microarrays is increasing in spectroscopic analysis, where specific molecular markers are targeted via immunostaining.
• Moreover, with the increase in the spending on research and development, there is increased adoption of tissue microarrays in the testing of drugs and biologics, driving the market growth. For instance, as per the PhRMA in July 2022, during the past 20 years, member companies have spent more than USD 1.1 trillion on the research and development of new medications. Therefore, the rising investments in R&D will lead to increased demand for tissue microarrays in the testing of samples, thereby propelling the market growth.
• However, the availability of alternative technologies and the high cost associated with microarray techniques are the factors hindering market growth.

Tissue Microarray Market Trends

Immunohistochemistry Segment is Expected to Hold a Significant Market Share in the Tissue Microarray Market

Tissue Microarray Industry Segmentation

Tissue microarrays are referred to as paraffin blocks produced by extracting cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a single recipient (microarray) block at defined array coordinates. 

The tissue microarray market is segmented by procedure (immunohistochemistry, fluorescence in situ hybridization (FISH), in situ hybridization, and other product types), technology (polymerase chain reaction, next-generation sequencing, DNA microarray, and other technology types), end-user (pharmaceutical and biotechnological companies, and research organizations, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. 

The report offers the value (in USD) for the above segments.